The Director of the Translational Neuropharmacology Lab, Dr. Zanos, presented our latest data concerning the potential role of NMDA receptor activation underlying ketamine’s antidepressant mechanism of action. This invited talk was a part of the Hellenic Society for Neuroscience (HSfN) conference. Dr. Zanos’s talk centered on revealing the crucial role of NMDA receptor activation in facilitating ketamine’s rapid antidepressant effects. This research illuminates potential pathways for the development of safer and more effective antidepressant interventions.

If you want to learn more about these advancements, read our new manuscript published in the Journal of Neuroscience recently: https://www.jneurosci.org/content/43/6/1038.abstract.

Stay tuned for future advancements in this exciting field.